A new treatment built from immune cells in the blood could be key to a quick, adaptable and low-risk way to heal wounds ...

The Central Drugs Standard Control Organization has published details of samples declared 'Not of Standard Quality' (NSQ) by ...

Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted for review GSK 's new drug application (NDA) for Blenrep ...

Pete O'Heeron, Founder and Chief Executive Officer of FibroBiologics, said, "This engagement is an important step forward in creating the infrastructure for FibroBiologics to conduct clinical trials ...

Hamilton Thorne Ltd (TSX: HTL) (“ Hamilton Thorne ” or the “ Company ”), a leading provider of precision instruments, consumables, software, and services to the Assisted Reproductive Technologies (“ ...

Merck and Daiichi Sankyo said a Phase 3 study evaluating patritumab deruxtecan in patients with locally advanced or metastatic EGFR-mutated non-small cell lung cancer who received prior EGFR tyrosine ...

PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company") a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today ...

Find out all you need to know about bispecific antibodies, including how they work and what the current clinical landscape ...

SES AI Corporation is advancing lithium-metal battery tech with AI, but faces financial issues and tough competition. Learn ...

The Clinical Trials Arena team investigates assets in infectious diseases, metabolic disorders, oncology and ophthalmology.

Australia has a reputation as an attractive clinical trials destination generating $1.6bn for the economy in 2022, according ...